DNA Script raised €31M in a Series C round in Jan 2022. The company is based in Paris, France. Investors in the round: Baillie Gifford, eureKARE, Healthcor Management and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
